Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Van Putten, Theodore
May, Philip R. A.
Marder, Stephen R.
Wilkins, Jeffery N.
and
Rosenberg, Burton J.
1983.
Plasma levels of thiothixene by radioreceptor assay: Clinical usefulness.
Psychopharmacology,
Vol. 79,
Issue. 1,
p.
40.
Tang, Siu Wa
Glaister, Joseph
Davidson, Lynne
Toth, Rebecca
Jeffries, Joel J.
and
Seeman, Philip
1984.
Total and free plasma neuroleptic levels in schizophrenic patients.
Psychiatry Research,
Vol. 13,
Issue. 4,
p.
285.
Fujii, Yasuo
Tateyama, Masato
Kamisada, Mamoru
Tanoue, Akira
Takamiya, Maki
Nakajima, Seiichiro
and
Itoh, Hitoshi
1984.
Clinical Efficacy, Extrapyramidal Symptoms and Serum Levels: Influence of Administration Schedules and Concomitant Drugs on Serum Bromperidol Concentrations.
Psychiatry and Clinical Neurosciences,
Vol. 38,
Issue. 2,
p.
121.
Davis, John M.
Javaid, Javaid I.
and
Matuzas, William
1984.
Handbook of Psychiatric Diagnostic Procedures Vol. I.
p.
131.
Curry, Stephen H.
1984.
Guidelines for the Use of Psychotropic Drugs.
p.
239.
Seeman, Mary V.
1984.
Guidelines for the Use of Psychotropic Drugs.
p.
169.
Knudsen, Peder
1985.
Chemotherapy With Neuroleptics.
Acta Psychiatrica Scandinavica,
Vol. 72,
Issue. S322,
p.
51.
Putten, Theodore Van
1985.
Biological Psychiatry, Higher Nervous Activity.
p.
509.
Tang, S.W.
1985.
Prediction of Treatment Response in Schizophrenia: Clinical Use of Neuroleptic Blood Levels.
The Canadian Journal of Psychiatry,
Vol. 30,
Issue. 4,
p.
249.
Rockland, Lawrence H.
1986.
Neuroleptic Blood Levels and Clinical Response.
The Canadian Journal of Psychiatry,
Vol. 31,
Issue. 4,
p.
299.
Turbott, John
Villiger, John
and
Hunter, Lynley
1987.
Depot Neuroleptic Medication and Serum Levels by Radioreceptor Assay: Prolactin Concentration, Electrocardiogram Abnormalities and Six-Month Outcome.
Australian & New Zealand Journal of Psychiatry,
Vol. 21,
Issue. 3,
p.
327.
Dahl, S. G.
and
Hals, P.-A.
1987.
Clinical Pharmacology in Psychiatry.
p.
266.
Smith, C.S.
Morgan, S.L.
Greene, S.V.
and
Abramson, R.K.
1987.
Solid-phase extraction and high-performance liquid chromatographic method for chlorpromazine and thirteen metabolites.
Journal of Chromatography B: Biomedical Sciences and Applications,
Vol. 423,
Issue. ,
p.
207.
Breyer-Pfaff, U.
1987.
Neuroleptika Rückschau 1952–1986, Künftige Entwicklungen.
p.
37.
Waraska, John
and
Nagle, John D.
1987.
A Critical Assessment of Antipsychotic Drug Monitoring.
Clinics in Laboratory Medicine,
Vol. 7,
Issue. 2,
p.
435.
Browne, F.W.A.
Cooper, S.J.
Wilson, R.
and
King, D.J.
1988.
Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patients.
Journal of Psychopharmacology,
Vol. 2,
Issue. 2,
p.
94.
Breyer-Pfaff, Ursula
1990.
Leitlinien neuroleptischer Therapie.
p.
25.
Dahl, S. G.
1990.
Thioxanthene.
p.
25.
Faraone, Stephen V.
Simpson, John C.
and
Brown, Walter A.
1992.
Mathematical models of complex dose‐response relationships: Implications for experimental design in psychopharmacologic research.
Statistics in Medicine,
Vol. 11,
Issue. 5,
p.
685.
Heininger, K.
Sieberns, S.
and
Gaebel, W.
1992.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
17.